Sensitivity and specificity of nucleic acid amplification tests for the diagnosis of pulmonary tuberculosis: a meta-analysis Source: Eur Respir J 2003; 22: Suppl. 45, 161s Year: 2003
Nucleic acid amplification improves the accuracy of sputum induction in the rapid diagnosis of pulmonary tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 419s Year: 2005
Role of specialists in the application of a nucleic acid amplification test for the rapid diagnosis of pulmonary tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 167s Year: 2002
The role of bronchoscopy and nucleic acid amplification test in pulmonary tuberculosis diagnosis Source: International Congress 2017 – TB: diagnosis, severity and practical management Year: 2017
Prevalence of positivity of CBNAAT(cartridge based nucleic acid amplification test) in extra-pulmonary tuberculosis. Source: International Congress 2018 – Pulmonary tuberculosis: long term complications, rehabilitation and challenges Year: 2018
Comparative evaluation of commercially available nucleic acid amplification tests in the diagnosis of smear-negative tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 581s Year: 2002
Semiquantitation of tuberculosis bacilli (MTB) and nontuberculous mycobacteria (NTM) in sputum by a new nucleic acid amplification test (NAAT) Source: International Congress 2018 – Diagnosis of tuberculosis Year: 2018
Comparison of Mycobacterium tuberculosis drug susceptibility tests by nucleic acid amplification and classic technique Source: Eur Respir J 2001; 18: Suppl. 33, 315s Year: 2001
Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis Source: Eur Respir J 2012; 40: 442-447 Year: 2012
Diagnostic value of PCR-RT for the detection of DNA Mycobacterium tuberculosis complex (MBT) in blood from patient with pulmonary tuberculosis (PT) Source: Annual Congress 2009 - Diagnostic advances in tuberculosis Year: 2009
Novel sequence-based assay for detection of pyrazinamide-resistant mycobacterium tuberculosis in clinical specimens from patients with pulmonary tuberculosis in Russia Source: Annual Congress 2011 - Tuberculosis: from bench to bedside Year: 2011
Economic evaluation of the use of PCR assay in diagnosing pulmonary TB in a low-incidence area Source: Eur Respir J 2004; 23: 446-451 Year: 2004
Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithms Source: Eur Respir J 2011; 39: 163-171 Year: 2012
Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithms Source: Eur Respir J 2012; 39: 163-171 Year: 2012
Determination of drug susceptibility of Mycobacterium tuberculosis through mycolic acid analysis with HPLC technique - comparison to the conventional methods Source: Annual Congress 2005 - Management of tuberculosis pulmonary, extrapulmonary peculiarities Year: 2005
GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis Source: Eur Respir J 2008; 32: 1165-1174 Year: 2008
GenoType MTBDRsl performance on clinical samples with diverse genetic background}, Source: Eur Respir J 2012; 40: 690-698 Year: 2012
Clinical evaluation of a diagnostic method of tuberculosis infection, QuantiFERON TB-2G, for active tuberculosis and nontuberculous mycobacteriosis Source: Eur Respir J 2006; 28: Suppl. 50, 139s Year: 2006
Diagnostic predictive factors for sputum smear acid fast bacillus negative pulmonary tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 427s Year: 2005
Application of the novel technique next gene sequencing for the determination of mycobacterium tuberculosis resistance in clinical samples Source: Annual Congress 2013 –Tuberculosis diagnosis Year: 2013